pharmaphorum mediaSummit enters biomarker collaboration for rare disease, Duchenne Muscular DystrophySummitSummit enters biomarker collaboration for rare disease, Duchenne Muscular Dystrophy
About this event
Summit has entered into a rare disease biomarkers collaboration, supported by a grant from the Foundation to Eradicate Duchenne. A UK drug discovery company has teamed up with Dr Yetrib Hathout from the Washington DC Children’s. Summit enters biomarker collaboration for rare disease, Duchenne Muscular Dystrophy is an official summit listing associated with pharmaphorum media.
Visit the company-owned event page for the organizer's latest agenda, access details, availability, and registration or viewing instructions. UPCOMING provides this independent listing to help professionals discover the session.
Topics covered
Frequently asked questions
Who is hosting Summit enters biomarker collaboration for rare disease, Duchenne Muscular Dystrophy?
Summit enters biomarker collaboration for rare disease, Duchenne Muscular Dystrophy is hosted by pharmaphorum media.
When is Summit enters biomarker collaboration for rare disease, Duchenne Muscular Dystrophy?
Summit enters biomarker collaboration for rare disease, Duchenne Muscular Dystrophy is scheduled for Monday, February 11, 2013.
Where does registration take place?
Registration or viewing is completed on pharmaphorum media's website.
What format is this event?
This is an online summit.
Which topics does this event cover?
The event covers Customer Experience and Data.
